These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6209387)

  • 1. Bleomycin hydrolase activity in pulmonary cells.
    Lazo JS; Merrill WW; Pham ET; Lynch TJ; McCallister JD; Ingbar DH
    J Pharmacol Exp Ther; 1984 Dec; 231(3):583-8. PubMed ID: 6209387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of bleomycin-resistant phenotypes of human cell sublines and circumvention of bleomycin resistance by liblomycin.
    Lazo JS; Braun ID; Labaree DC; Schisselbauer JC; Meandzija B; Newman RA; Kennedy KA
    Cancer Res; 1989 Jan; 49(1):185-90. PubMed ID: 2461797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleomycin hydrolase activity and cytotoxicity in human tumors.
    Lazo JS; Boland CJ; Schwartz PE
    Cancer Res; 1982 Oct; 42(10):4026-31. PubMed ID: 6179595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralization of bleomycin hydrolase by an epitope-specific antibody.
    Morris G; Mistry JS; Jani JP; Mignano JE; Sebti SM; Lazo JS
    Mol Pharmacol; 1992 Jul; 42(1):57-62. PubMed ID: 1378925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of erythrocytes on alveolar macrophage cytostatic activity induced by bleomycin lung damage in rats.
    Huot AE; Gundel RM; Hacker MP
    Cancer Res; 1990 Apr; 50(8):2351-5. PubMed ID: 1690596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate specificity of bleomycin hydrolase.
    Sebti SM; DeLeon JC; Ma LT; Hecht SM; Lazo JS
    Biochem Pharmacol; 1989 Jan; 38(1):141-7. PubMed ID: 2462878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separation of the protective enzyme bleomycin hydrolase from rabbit pulmonary aminopeptidases.
    Sebti SM; Lazo JS
    Biochemistry; 1987 Jan; 26(2):432-7. PubMed ID: 3103681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification, characterization, and amino acid composition of rabbit pulmonary bleomycin hydrolase.
    Sebti SM; DeLeon JC; Lazo JS
    Biochemistry; 1987 Jul; 26(14):4213-9. PubMed ID: 3117099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lidocaine potentiation of bleomycin A2 cytotoxicity and DNA strand breakage in L1210 and human A-253 cells.
    Lazo JS; Braun ID; Meandzija B; Kennedy KA; Pham ET; Smaldone LF
    Cancer Res; 1985 May; 45(5):2103-9. PubMed ID: 2580616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yeast cysteine proteinase gene ycp1 induces resistance to bleomycin in mammalian cells.
    Pei Z; Calmels TP; Creutz CE; Sebti SM
    Mol Pharmacol; 1995 Oct; 48(4):676-81. PubMed ID: 7476893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary fate of [3H]bleomycin A2 in mice.
    Lazo JS; Pham ET
    J Pharmacol Exp Ther; 1984 Jan; 228(1):13-8. PubMed ID: 6198509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleomycin inhibition of angiotensin-converting enzyme activity from serum, lungs, and cultured pulmonary artery endothelial cells.
    Lazo JS; Lynch TJ; McCallister J
    Am Rev Respir Dis; 1986 Jul; 134(1):73-8. PubMed ID: 2425674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of metabolism as the biochemical basis of bleomycin-induced pulmonary toxicity.
    Lazo JS; Humphreys CJ
    Proc Natl Acad Sci U S A; 1983 May; 80(10):3064-8. PubMed ID: 6190169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bleomycin hydrolase: molecular cloning, sequencing, and biochemical studies reveal membership in the cysteine proteinase family.
    Sebti SM; Mignano JE; Jani JP; Srimatkandada S; Lazo JS
    Biochemistry; 1989 Aug; 28(16):6544-8. PubMed ID: 2477059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic inactivation: a mechanism of human tumor resistance to bleomycin.
    Sebti SM; Jani JP; Mistry JS; Gorelik E; Lazo JS
    Cancer Res; 1991 Jan; 51(1):227-32. PubMed ID: 1703034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Species variation in pulmonary endothelial aminopeptidase P activity.
    Chen X; Orfanos SE; Ryan JW; Chung AY; Hess DC; Catravas JD
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1301-7. PubMed ID: 1762077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-dependent apoptosis of alveolar macrophages from rats exposed to bleomycin: involvement of tnf receptor 2.
    Zhao HW; Hu SY; Barger MW; Ma JK; Castranova V; Ma JY
    J Toxicol Environ Health A; 2004 Sep; 67(17):1391-406. PubMed ID: 15371238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleomycin induces E-selectin expression in cultured umbilical vein endothelial cells by increasing its mRNA levels through activation of NF-kappaB/Rel.
    Ishii H; Takada K
    Toxicol Appl Pharmacol; 2002 Oct; 184(2):88-97. PubMed ID: 12408953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of emodin on bleomycin-induced pulmonary fibrosis in mice.
    Chen XH; Sun RS; Hu JM; Mo ZY; Yang ZF; Jin GY; Guan WD; Zhong NS
    Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):146-53. PubMed ID: 18785980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes of tight junction and Cx43 expression in microvessel endothelial cells of mouse lung induced by bleomycin].
    Cui GB; Wei JG; Wang W; Yin Q; Wang CM; Wei LX; Yang H
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Feb; 24(2):99-102. PubMed ID: 16600115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.